Kronos Bio, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ACHL
Achilles Therapeutics plc |
$1.14 | $37.06 M | -0.56 | 204 | $0 |
ADXN
Addex Therapeutics Ltd |
$7.99 | $13.74 M | -0.48 | 23 | $1.61 M |
ASMB
Assembly Biosciences, Inc. |
$14.72 | $78.73 M | -1.35 | 65 | $7.16 M |
CCCC
C4 Therapeutics, Inc. |
$3.87 | $320.64 M | -1.97 | 145 | $20.76 M |
CRNX
Crinetics Pharmaceuticals, Inc. |
$53.94 | $3.53 B | -11.86 | 290 | $4.01 M |
CTMX
CytomX Therapeutics, Inc. |
$1.07 | $127.79 M | 7.81 | 120 | $101.21 M |
CYCN
Cyclerion Therapeutics, Inc. |
$3.29 | $6.91 M | -0.56 | 1 | $0 |
ERAS
Erasca, Inc. |
$2.57 | $647.94 M | -2.83 | 126 | $0 |
EWTX
Edgewise Therapeutics, Inc. |
$29.62 | $1.65 B | -11.47 | 108 | $0 |
GBIO
Generation Bio Co. |
$1.07 | $216.88 M | -1.28 | 174 | $5.90 M |
GOSS
Gossamer Bio, Inc. |
$0.84 | $124.06 M | -0.65 | 135 | $0 |
INBX
Inhibrx Biosciences, Inc. |
$14.49 | $241.02 M | -1.44 | 166 | $1.80 M |
LRMR
Larimar Therapeutics, Inc. |
$3.78 | $611.84 M | -9.99 | 42 | $0 |
LYEL
Lyell Immunopharma, Inc. |
$0.61 | $619.50 M | -2.7 | 224 | $130,000 |
LYRA
Lyra Therapeutics, Inc. |
$0.17 | $19.53 M | -0.27 | 88 | $1.56 M |
MRUS
Merus N.V. |
$42.41 | $3.50 B | -19.38 | 172 | $43.95 M |
NLTX
Neoleukin Therapeutics, Inc. |
$3.49 | $8.20 M | -0.28 | 7 | $0 |
NVCT
Nuvectis Pharma, Inc. |
$4.65 | $116.38 M | -4.5 | 13 | $0 |
NXTC
NextCure, Inc. |
$0.87 | $38.88 M | -0.61 | 82 | $0 |
REPL
Replimune Group, Inc. |
$12.50 | $485.18 M | -2.44 | 331 | $0 |
SPRO
Spero Therapeutics, Inc. |
$0.94 | $75.85 M | 3.19 | 46 | $96.74 M |